ANGO News and Press, AngioDynamics Inc. From 09/30/21

The following slide deck was published by AngioDynamics, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: AngioDynamics, Inc. 2022 Q4 - Results - Earnings Call Presentation

Image source: The Motley Fool. Angiodynamics Inc (NASDAQ: ANGO) Q1 2022 Earnings Call Sep 30, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Angiodynamics Inc (ANGO) Q1 2022 Earnings Call Transcript

Fiscal 2022 First Quarter Highlights Net sales of $77.0 million increased 9.6% compared to the prior-year quarter Gross margin of 52.1% increased 120 basis points year over year GAAP loss per share of $0.18, and adjusted loss per share of $0.02 Th...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2022 before the market open...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice Presid...

AngioDynamics saw a stronger-than-expected rebound with FQ4 revenue, and boosted guidance for FY'22, while also providing an encouraging three-year outlook for meaningful growth acceleration. Management is focusing on three primary growth platforms - thrombectomy, peripheral atherecto...

Many investors may never have heard of AngioDynamics (NASDAQ: ANGO) , which produces "minimally invasive medical devices" to treat peripheral vascular disease and cancer, according to its website. Some, however, may have taken notice after the July 13 announcement of net sales f...

The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...

AngioDynamics, Inc. (ANGO) Q4 2021 Earnings Conference Call July 13, 2021 08:00 AM ET Company Participants Jim Clemmer - President and Chief Executive Officer Steve Trowbridge - Executive Vice President and Chief Financial Officer Conference Call Participants Matthew Mishan - KeyBanc Capital ...

Image source: The Motley Fool. Angiodynamics Inc (NASDAQ: ANGO) Q4 2021 Earnings Call Jul 13, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Angiodynamics Inc (ANGO) Q4 2021 Earnings Call Transcript